Sao Paulo, December 2020 – Eurofarma, a Brazilian multinational company with operations in 20 Latin American countries, was one of the winners of Ispe Brazil Awards, in the ‘Industry of the Year’ category. The virtual awards took place on the evening of December 17.

Established in the country 20 years ago, Ispe Brasil is an independent affiliate of the International Association of Pharmaceutical Engineering (Ispe), and has been organizing this event for 12 years. Nominees will compete in four categories: Associate of the Year, Committee of the Year, Industry of the Year and Company of the Year.

“Ispe is an excellent forum for fostering discussions and sharing ideas and knowledge. Besides, it offers a great opportunity to strengthen relationships. We are thrilled to receive an award for our participation,” said Vanessa Moreira, supervisor of the Validation area at Eurofarma.

To be recognized as Industry of the Year, companies must be directly involved with Ispe Brasil, with employees attending events, meetings, and working groups and as speakers of events held by the institution, with the aim of contributing to the development of the Life Sciences Industries in Brazil.

Established in the United States in 1980, Ispe is a non-profit organization focused on the development and dissemination of knowledge and best manufacturing practices for professionals dedicated to research, production and distribution of quality medicines for human consumption.

About Eurofarma Group

As the first multinational pharmaceutical company with 100% Brazilian capital, the Eurofarma Group has been operating in the health industry since its establishment in 1972, producing and marketing innovative products and services to improve people’s quality of life. Focused on generating shared value, it operates in the areas of Prescription, Non-Prescription, and Generic Drugs, Hospital, Oncology and Veterinary. In Brazil alone, it offers 313 products, 649 dosage forms, serves 25 medical specialties and covers 89 therapeutic classes, which represent 81% of prescriptions in the brand market.

The Eurofarma Group has own operations in 20 countries, with an industrial park in Brazil and plants in 6 more Latin American countries. Reported sales totaled BRL 5.6 billion in 2019 and the Group employs over 7,000 employees.